adenine has been researched along with Pyoderma Gangrenosum in 2 studies
Pyoderma Gangrenosum: An idiopathic, rapidly evolving, and severely debilitating disease occurring most commonly in association with chronic ulcerative colitis. It is characterized by the presence of boggy, purplish ulcers with undermined borders, appearing mostly on the legs. The majority of cases are in people between 40 and 60 years old. Its etiology is unknown.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giovanni, B | 1 |
| Ibatici, A | 1 |
| Sola, S | 1 |
| Brunasso, AMG | 1 |
| Massone, C | 1 |
| Sławińska, M | 1 |
| Barańska-Rybak, W | 1 |
| Sobjanek, M | 1 |
| Wilkowska, A | 1 |
| Mital, A | 1 |
| Nowicki, R | 1 |
2 other studies available for adenine and Pyoderma Gangrenosum
| Article | Year |
|---|---|
Ibrutinib and Pyoderma Gangrenosum in a Patient With B-Cell Chronic Lymphocytic Leukemia.
Topics: Adenine; Antineoplastic Agents; Drug Eruptions; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male | 2020 |
Ibrutinib-induced pyoderma gangrenosum.
Topics: Adenine; Cyclosporine; Drug Therapy, Combination; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Ma | 2016 |